Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Long-Term Deferred Tax (2016 - 2020)

Cumberland Pharmaceuticals' Long-Term Deferred Tax history spans 10 years, with the latest figure at $21802.0 for Q3 2020.

  • For Q3 2020, Long-Term Deferred Tax fell 50.0% year-over-year to $21802.0; the TTM value through Sep 2020 reached $21802.0, down 50.0%, while the annual FY2019 figure was $21802.0, 75.0% down from the prior year.
  • Long-Term Deferred Tax for Q3 2020 was $21802.0 at Cumberland Pharmaceuticals, roughly flat from $21802.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $3.5 million in Q1 2017 and bottomed at $21802.0 in Q4 2019.
  • The 5-year median for Long-Term Deferred Tax is $65407.5 (2017), against an average of $522249.0.
  • The largest annual shift saw Long-Term Deferred Tax soared 157.68% in 2016 before it tumbled 97.53% in 2018.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $3.1 million in 2016, then tumbled by 97.2% to $87210.0 in 2017, then changed by 0.0% to $87210.0 in 2018, then tumbled by 75.0% to $21802.0 in 2019, then changed by 0.0% to $21802.0 in 2020.
  • Per Business Quant, the three most recent readings for CPIX's Long-Term Deferred Tax are $21802.0 (Q3 2020), $21802.0 (Q2 2020), and $21802.0 (Q1 2020).